You have 9 free searches left this month | for more free features.


Showing 1 - 25 of 3,247


Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)

  • Urinary Bladder Cancer
  • Carboplatin-Gemcitabine Cisplatin-Gemcitabine
  • Assiut, Egypt
Apr 22, 2023

Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer
  • Canagliflozin and Gemcitabine
  • Gemcitabine
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Jun 11, 2023

Metastatic Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Weiden (nab-paclitaxel and gemcitabine, gemcitabine mono

  • Metastatic Pancreatic Cancer
  • Adenocarcinoma of the Pancreas
  • nab-paclitaxel and gemcitabine
  • gemcitabine mono and nab-paclitaxel and gemcitabine
  • Weiden, Germany
    Kliniken Nordoberpfalz AG, Klinikum Weiden
Nov 21, 2022

Nasopharyngeal Carcinoma Trial in Xi'an (gemcitabine,nimotuzumab, toripalimab, gemcitabine, cisplatin)

  • Nasopharyngeal Carcinoma
  • gemcitabine,nimotuzumab, toripalimab
  • gemcitabine, cisplatin
  • Xi'an, Shaanxi, China
    Department of Radiation Oncology, Xijing Hospital, Fourth Milita
Sep 5, 2023

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Gemcitabine
  • +2 more
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Biliary Tract Cancer Trial in Worldwide (Durvalumab, Gemcitabine monotherapy, Gemcitabine + cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Durvalumab
  • +7 more
  • Orange, California
  • +36 more
Mar 6, 2023

Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

Active, not recruiting
  • Ovarian Cancer
  • Platinum-resistant Ovarian Cancer
  • Gemcitabine
  • Minsk, Belarus
    Minsk City Clinical Oncology Center
Jul 27, 2023

Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Cholangiocarcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2023

PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

Not yet recruiting
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
  • (no location specified)
Jul 9, 2023

Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)

Not yet recruiting
  • Hydroxychloroquine
  • +2 more
  • Hydroxychloroquine Combined With Gemcitabine
  • (no location specified)
Dec 3, 2022

Pancreatic Tumors Trial in Shanghai (Utidelone injection in combination with gemcitabine)

  • Pancreatic Neoplasms
  • Utidelone injection in combination with gemcitabine
  • Shanghai, Shanghai, China
    Shanghai First People's Hospital
Mar 21, 2023

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

NMIBC Trial in Beijing (RC48-ADC in Combination with gemcitabine)

  • RC48-ADC in Combination with gemcitabine
  • Beijing, Beijing, China
    Peking University First Hosptital
Jul 10, 2023

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Gemcitabine
  • Nab paclitaxel
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Gemcitabine
  • +2 more
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy Trial in México (Gemcitabine, Cisplatin)

  • Locally Advanced Cervical Cancer
  • +2 more
  • México, Ciudad De México, Mexico
    National Cancer Institute of Mexico
Nov 27, 2023

Advanced Cholangiocarcinoma Trial in Hangzhou (Lenvatinib, tislelizumab, gemcitabine and cisplatin, Gemcitabine and cisplatin)

Not yet recruiting
  • Advanced Cholangiocarcinoma
  • Lenvatinib, tislelizumab, gemcitabine and cisplatin
  • Gemcitabine and cisplatin
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital, Zhejiang University School of Me
Apr 10, 2023

Pancreatic Cancer Trial in Tianjin (surufatinib + gemcitabine + nab-paclitaxel)

  • Pancreatic Cancer
  • surufatinib + gemcitabine + nab-paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jun 15, 2023

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Gemcitabine
  • +3 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Cancer Of Pancreas Trial (Analyze of GemCore status)

Not yet recruiting
  • Cancer Of Pancreas
  • Analyze of GemCore status
  • (no location specified)
Sep 19, 2023

HER2 Gene Mutation Trial in Shanghai (Injection of IAH0968+Gemcitabine+Cisplatin, Gemcitabine+Cisplatin)

  • HER2 Gene Mutation
  • Injection of IAH0968+Gemcitabine+Cisplatin
  • Gemcitabine+Cisplatin
  • Shanghai, China
    Fudan University Affiliated Zhongshan Hospital
Aug 7, 2023

Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

  • Nasopharyngeal Carcinoma
  • Endostar and Envafolimab
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 24, 2023

NSCLC Trial (Milciclib Dose: 150 mg/day Mode of administration: oral)

Not yet recruiting
  • Milciclib Dose: 150 mg/day Mode of administration: oral
  • (no location specified)
Dec 12, 2022

Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)

Not yet recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • (no location specified)
Feb 17, 2023